These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24286415)

  • 21. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.
    Bhargava A; Hayakawa K; Silverman E; Haider S; Alluri KC; Datla S; Diviti S; Kuchipudi V; Muppavarapu KS; Lephart PR; Marchaim D; Kaye KS
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):398-405. PubMed ID: 24602945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
    Schwartz-Neiderman A; Braun T; Fallach N; Schwartz D; Carmeli Y; Schechner V
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1219-25. PubMed ID: 27452597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active surveillance of carbapenem-resistant Enterobacteriaceae in intensive care units: Is it cost-effective in a nonendemic region?
    Ho KW; Ng WT; Ip M; You JH
    Am J Infect Control; 2016 Apr; 44(4):394-9. PubMed ID: 26698671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of Persistent Carbapenem-Resistant Enterobacteriaceae Carriage upon Readmission and Score Development.
    Ciobotaro P; Flaks-Manov N; Oved M; Schattner A; Hoshen M; Ben-Yosef E; Balicer RD; Zimhony O
    Infect Control Hosp Epidemiol; 2016 Feb; 37(2):188-96. PubMed ID: 26750741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors for Recurrence of Carbapenem-Resistant Enterobacteriaceae Carriage: Case-Control Study.
    Bart Y; Paul M; Eluk O; Geffen Y; Rabino G; Hussein K
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):936-41. PubMed ID: 25869912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
    Thiébaut AC; Arlet G; Andremont A; Papy E; Sollet JP; Bernède-Bauduin C; Guillemot D; Schlemmer B;
    J Antimicrob Chemother; 2012 Jun; 67(6):1525-36. PubMed ID: 22441577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbapenem-resistant Enterobacteriaceae on a cardiac surgery intensive care unit: successful measures for infection control.
    Abboud CS; de Souza EE; Zandonadi EC; Borges LS; Miglioli L; Monaco FC; Barbosa VL; Cortez D; Bianco AC; Braz A; Monteiro J
    J Hosp Infect; 2016 Sep; 94(1):60-4. PubMed ID: 27451040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of ethylene oxide gas sterilization of duodenoscopes after a carbapenem-resistant Enterobacteriaceae outbreak.
    Naryzhny I; Silas D; Chi K
    Gastrointest Endosc; 2016 Aug; 84(2):259-62. PubMed ID: 26855298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.
    Friedman ND; Carmeli Y; Walton AL; Schwaber MJ
    Infect Control Hosp Epidemiol; 2017 May; 38(5):580-594. PubMed ID: 28294079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.
    Gupta N; Limbago BM; Patel JB; Kallen AJ
    Clin Infect Dis; 2011 Jul; 53(1):60-7. PubMed ID: 21653305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?
    Yamamoto M; Pop-Vicas AE
    Crit Care; 2014 Jun; 18(3):229. PubMed ID: 25041592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of use of infection control precautions for multiresistant gram-negative bacilli in Australian hospitals: analysis of a national survey.
    Rogers BA; Havers SM; Harris-Brown TM; Paterson DL
    Am J Infect Control; 2014 Sep; 42(9):963-9. PubMed ID: 25179327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention.
    Brink A; Coetzee J; Clay C; Corcoran C; van Greune J; Deetlefs JD; Nutt L; Feldman C; Richards G; Nordmann P; Poirel L
    S Afr Med J; 2012 May; 102(7):599-601. PubMed ID: 22748433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate of colonization of health care workers by carbapenem-resistant Enterobacteriaceae in an endemic hospital: A prospective study.
    Bitterman R; Geffen Y; Rabino G; Eluk O; Warman S; Greenblatt AS; Neuberger A; Reisner SA; Hussein K; Paul M
    Am J Infect Control; 2016 Sep; 44(9):1053-4. PubMed ID: 27125914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.
    Logan LK; Renschler JP; Gandra S; Weinstein RA; Laxminarayan R; ;
    Emerg Infect Dis; 2015 Nov; 21(11):2014-21. PubMed ID: 26486124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae.
    Prinapori R; Guinaud J; Khalil A; Lecuyer H; Gendrel D; Lortholary O; Nassif X; Viscoli C; Zahar JR
    Am J Infect Control; 2013 Mar; 41(3):259-60. PubMed ID: 23062579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals.
    Knight GM; Dyakova E; Mookerjee S; Davies F; Brannigan ET; Otter JA; Holmes AH
    BMC Med; 2018 Aug; 16(1):141. PubMed ID: 30111322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbapenem-Resistant Enterobacteriaceae Transmission in Health Care Facilities - Wisconsin, February-May 2015.
    Elbadawi LI; Borlaug G; Gundlach KM; Monson T; Warshauer D; Walters MS; Kallen A; Gulvik CA; Davis JP
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(34):906-9. PubMed ID: 27584864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between infection control interventions and carbapenem-resistant Enterobacteriaceae incidence in an endemic hospital.
    Hussein K; Rabino G; Eluk O; Warman S; Reisner S; Geffen Y; Halif L; Paul M
    J Hosp Infect; 2017 Nov; 97(3):218-225. PubMed ID: 28743504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.